Introduction {#Sec1}
============

Pathogenic microorganisms adapt to host environments and cause various infectious diseases. Many of the pathogens, which cause systemic infections through the bloodstream, form biofilms on the surface of medical devices \[[@CR1], [@CR2]\]. Biofilm infections can have disastrous consequences, as biofilm cells embedded with extracellular matrix are usually resistant to both antimicrobial agents and host immune systems \[[@CR3]\]. The cells themselves also change expression levels of resistance-related genes. Finally, dispersion of biofilms leads to systemic infections. When biofilm infections occur, surgical removal of the infected device is required. Therefore, biofilm formation on the surface of medical devices is a problem in clinical settings.

*Trichosporon asahii* is a major causative pathogenic fungus of deep-seated trichosporonosis and can form biofilms on various medical device substrates \[[@CR4]\]. Deep-seated trichosporonosis develops in immunocompromised patients, specifically in those with hematological malignancies accompanied by neutropenia, such as leukemia. *T. asahii* is the third most common etiological agent of fungemia, after *Candida* species and *Cryptococcus* species \[[@CR5], [@CR6]\]. *Candida albicans*, a representative dimorphic fungus, forms biofilms on the surface of medical devices \[[@CR7], [@CR8]\]. *T. asahii* is also a dimorphic fungus with a yeast form, hyphal form, and arthroconidia that disarticulate from hyphae \[[@CR9]\]. Because of the commonality in morphological transition, between the two organisms, the literature on *C. albicans*-infections provides important background to the present study. The clinical outcome of disseminated trichosporonosis is poorer than that of disseminated candidiasis caused by *Candida* species \[[@CR5]\]; the mortality rate is over 70% \[[@CR10], [@CR11]\]. Recently, disseminated trichosporonosis has frequently been reported in immunocompromised patients on echinocandin treatment, because *Trichosporon* species are highly resistant to the echinocandins \[[@CR12], [@CR13]\]. Infections caused by *Trichosporon* species have become more increasing since the use of echinocandins, which are first-line antifungal agents used in emergency and intensive care medicine. Therefore, preventive methods are required to inhibit biofilm formation, which contributes to deep-seated trichosporonosis \[[@CR4]\].

We previously found that the expression of *Pra1* and *Zrt1* genes involved in zinc utilization in *C. albicans* was greater in biofilms than in planktonic cells \[[@CR14]\]. The *pra1* and *zrt1* gene-deficient strains exhibited decreased abilities to form biofilms and also hyphae, which are essential for biofilm formation \[[@CR14]\]. Moreover, zinc addition caused increased biofilm formation, and zinc depletion by a chelator inhibited biofilm formation in *C. albicans* \[[@CR14]\]. These findings suggest that zinc is a key metal for biofilm formation in *C. albicans*. However, the importance of zinc for biofilm formation in *T. asahii* remains poorly understood.

In this study, we evaluated the effects of cation chelators on biofilm formation by *T*. *asahii*. *N*,*N*,*N′,N′*-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), a cation chelator, effectively inhibited biofilm formation by *T*. *asahii* and reduced hyphal formation. The inhibitory effects of TPEN were eliminated by the addition of excess amounts of zinc. Our findings suggest that zinc is a key metal for biofilm formation by *T. asahii* and that TPEN is a potent inhibitor of biofilm formation.

Main text {#Sec2}
=========

Materials and methods {#Sec3}
---------------------

### Reagents {#Sec4}

Four chelators were examined in this study: TPEN (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan), deferoxamine (DFO; Abcam, Cambridge, UK), and triethylenetetramine (TETA; Nacalai Tesque, Kyoto, Japan), which predominately chelate Zn^2+^, Fe^2+^ and Cu^2+^, respectively, and ethylenediaminetetraacetic acid (EDTA; Nippon Gene Co., Ltd, Tokyo, Japan), which predominantly chelates divalent cations such as Mg^2+^ and Ca^2+^. Tested final concentrations were \[0, 0.01, 0.1, 1, 10, 100 μM\] for TPEN, \[0, 50, 500, 5000, 50,000 μM\] for DFO and \[0, 5, 50, 500, 5000 μM\] for TETA and EDTA. TPEN was dissolved in DMSO. DFO, TETA and EDTA were dissolved in sterile water. All stock solutions were stored at − 30 °C until use.

### *T. asahii* culture {#Sec5}

The stock strain, *T. asahii* MPU 105, which is highly able to form biofilms, was selected from the MPU culture collection, and the strain was isolated from the blood of patient. The strain was routinely grown on Sabouraud dextrose agar plates at 27 °C.

### Biofilm formation {#Sec6}

Biofilms formed from cells grown in flat-bottomed, 96-well microtiter plates. Standardized cell suspensions (A~630~ = 0.1 in RPMI 1640-plus-MOPS medium, pH 7.0) were seeded into each well. The plates were incubated without shaking at 37 °C for 1 h, and then the supernatants were removed and the cells were washed with PBS. Next, fresh medium was added, followed by incubation without shaking at 37 °C, and then the supernatants were removed after 24 h and replaced with fresh medium. Planktonic cells were removed after an additional 24 h incubation and the wells were washed with PBS. Semiquantitative evaluation of biofilm formation was performed using the XTT reduction assay. Absorbance was measured at wavelengths of 492 and 630 nm.

### Microscopic analysis {#Sec7}

*T*. *asahii* cells (A~630~ = 0.1) were added to RPMI 1640-plus-MOPS medium with each concentration of TPEN and ZnSO~4~ in 96-well plates and incubated without shaking at 37 °C for 48 h. Controls (no TPEN or ZnSO~4~) included the same amount of solvent as the other samples. Morphological changes were microscopically evaluated.

### Statistical analysis {#Sec8}

The significance of differences between groups was calculated using a Student's *t* test. *P *\< 0.05 was considered a statistically significant difference.

Results {#Sec9}
-------

We tested whether biofilm formation by *T. asahii* was inhibited by the cation chelators TPEN, DFO, TETA, and EDTA. TPEN, EDTA, and TETA reduced biofilm formation in a concentration-dependent manner (Fig. [1](#Fig1){ref-type="fig"}). DFO did not obviously inhibit biofilm growth at 50 mM (Fig. [1](#Fig1){ref-type="fig"}). IC~50~ values (the concentration of a compound required for the half inhibition of biofilm formation) of TPEN, TETA, and EDTA were 0.17 µM, 117 µM, and 47 µM, respectively. TPEN was the most effective cation chelator to inhibit biofilm formation by *T. asahii*.Fig. 1Biofilm formation in the presence of divalent chelators Biofilms were incubated in RPMI-plus-MOPS medium with the following cation chelators: **a***N*,*N*,*N′,N′*-tetrakis(2-pyridylmethyl)ethylenediamine, **b** deferoxamine, **c** triethylenetetramine, and **d** ethylenediaminetetraacetic acid. Controls included the same amount of each solvent without chelators. Biofilm formation was measured using the XTT reduction assay. Measurements were performed four times under each condition, and data are expressed as means ± standard deviations. \**P *\< 0.05 compared to controls

TPEN has been used as a zinc chelator in several studies \[[@CR15]--[@CR17]\]. Therefore, we tested the effect of zinc on biofilm formation by *T. asahii*. Adding 1 to 10 µM of zinc increased biofilm formation, while high concentration of zinc decreased biofilm formation (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). Zinc suppressed the inhibitory effects of TPEN on biofilm formation by *T. asahii* (Fig. [2](#Fig2){ref-type="fig"}). Moreover, the addition of excess amounts of zinc led to an increase in biofilm formation by *T. asahii* (Fig. [2](#Fig2){ref-type="fig"}). These results suggest that zinc is an important metal for biofilm formation by *T. asahii*. We examined whether the inhibitory effect of TPEN was reversible by removing TPEN from the medium. After 1 h or 24 h treatment with TPEN, TPEN was removed by changing the medium (Additional file [2](#MOESM2){ref-type="media"}: Figure S2a). Biofilm formation by *T. asahii* was increased by removing TPEN (Additional file [2](#MOESM2){ref-type="media"}: Figure S2b). The effect of zinc addition was also observed in this assay (Additional file [2](#MOESM2){ref-type="media"}: Figure S2b). These results indicate that TPEN treatment did not kill all *T. asahii* cells and that the inhibitory effect of TPEN was reversible.Fig. 2Biofilm inhibition by *N*,*N*,*N′,N′*-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) is abrogated by zinc Biofilms were incubated in medium including 0.1 μM TPEN and 0.01--10 μM zinc, respectively. Controls (no TPEN, no ZnSO4) included the same amount of each solvent. Biofilm formation was measured using the XTT reduction assay. Measurements were performed four times under each condition, and data are expressed as means ± standard deviations. \**P *\< 0.05 relative to controls (decrease). +*P*\<0.05 relative to DMSO controls (increase)

We next examined morphological changes induced by TPEN. Control cells formed hyphae and arthroconidia. In the presence of 0.1 μM TPEN, hyphal formation decreased, whereas zinc addition induced hyphal elongation (Fig. [3](#Fig3){ref-type="fig"}). These results suggest that zinc regulated hyphal formation of *T*. *asahii*.Fig. 3Effect of *N*,*N*,*N′,N′*-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) and zinc on morphological transitions in *T*. *asahii T*. *asahii* was cultured in RPMI-plus-MOPS medium containing TPEN, zinc, or TPEN plus zinc, at 37 °C. Controls (no TPEN, no ZnSO4) included the same amount of each solvent. Cells were observed under a light microscope after 48 h incubation

Discussion {#Sec10}
----------

In this study, the cation chelator TPEN inhibited biofilm formation and hyphal elongation in *T*. *asahii*. Zinc triggered hyphal elongation and enhanced biofilm formation. Only morphological transition in response to TPEN or zinc was observed in planktonic cells in this study. Direct observation of biofilm structure changes instigated by TPEN or zinc is an area for future research. Our findings suggest that *T. asahii* uses zinc as an environmental indicator.

In *C*. *albicans*, zinc is important in terms of both biofilm development and maintenance. The expression of genes related to zinc acquisition increases in biofilm cells of *C*. *albicans* \[[@CR14], [@CR18]\]. Our previous report suggested that *C. albicans* biofilm formation is regulated by zinc and that TPEN inhibits biofilm formation \[[@CR14]\]. Depletion of divalent cations, such as iron, calcium, and magnesium, inhibit biofilm formation by *Aspergillus fumigatus* and *Cryptococcus neoformans* \[[@CR19], [@CR20]\]. In a murine model of invasive pulmonary aspergillosis caused by pathogenic fungus *Aspergillus fumigatus*, TPEN improved survival \[[@CR16]\]. In vivo experiments to evaluate the inhibitory effect of TPEN on biofilm formation by *T. asahii* are areas for future research.

Zinc also promotes biofilm formation by the pathogenic bacterium *Streptococcus pneumoniae* \[[@CR21]\]. Derivatives of 2-aminobenzimidazole inhibit biofilm development in methicillin-resistant *S*. *aureus*, vancomycin-resistant *Enterococcus faecium* and *S*. *epidermidis*, by chelating zinc \[[@CR22]\]. In *S*. *aureus*, zinc activates intercellular adhesion during biofilm formation \[[@CR23]\]. Thus, zinc may play a pivotal role in biofilm formation in both eukaryotes and prokaryotes. Therefore, cation chelators effectively prevent and treat biofilm-related infections.

In conclusion, zinc chelating has the potential to inhibit biofilm formation by *T. asahii*. Although further research is essential, TPEN could potentially be applied to catheters to prevent biofilm formation. The information may contribute to the prevention of biofilm formation by *T. asahii* on the surface of medical devices.

Limitations {#Sec11}
===========

The results of this study are limited to in vitro conditions and a single *T. asahii* strain. Further in vivo studies are required to clarify whether zinc deficiency through cation chelation would be effective against *T. asahii* biofilm infections. Also, studies using a wide variety and number of strains are recommended.
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**Additional file 1: Fig. S1.** Biofilm formation in the presence of zinc, and absence of chelators Biofilms were incubated in medium including 1--500 μM ZnSO~4~. Controls (no ZnSO4) included the same amount of each solvent. Biofilm formation was measured using an XTT reduction assay. Measurements were performed four times under each condition, and data are expressed as means ± standard deviations. \**P *\< 0.05 relative to controls (decrease). +*P*\<0.05 relative to DMSO controls (increase). **Additional file 2: Fig. S2.** Enhancement of biofilm formation by zinc. **a** Experimental scheme. Biofilms were grown for 1 h or 24 h in medium containing *N*,*N*,*N′,N′*-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), after which the medium was removed and replaced with TPEN-free medium or TPEN-free medium containing zinc. We included medium, dimethyl sulfoxide (DMSO), and TPEN controls. TPEN was added to 0.1 μM and zinc to 1 or 10 μM. Biofilm formation was measured using the XTT reduction assay. **b** Measurements were performed four times under each condition, and data are expressed as means ± standard deviations. \**P *\< 0.05 relative to DMSO controls (decrease). +*P*\<0.05 relative to DMSO controls (increase). ++*P *\< 0.05 relative to both DMSO and medium controls (increase).
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